文章摘要
杜 琎,石开虎,赵 扬,胡定辉,李 航,刘尊涛.丹参酚酸B通过抑制PI3K/AKT/mTOR通路促进自噬减轻大鼠心肌纤维化的研究[J].,2019,19(20):3812-3817
丹参酚酸B通过抑制PI3K/AKT/mTOR通路促进自噬减轻大鼠心肌纤维化的研究
A Study of Reducing Rat Myocardial Fibrosis by Promoting the Autophagy Resulting from the Inhibition of PI3K/AKT/mTOR Pathway by Salvianolic acid B (SA-B)
投稿时间:2019-03-13  修订日期:2019-04-09
DOI:10.13241/j.cnki.pmb.2019.20.003
中文关键词: 丹参酚酸B  自噬  心肌纤维化  PI3K/AKT/mTOR  Beclin1  LC3-II  Western blot
英文关键词: Salvianolic acid B  Autophagy  Myocardial fibrosis  PI3K/AKT/ mTOR  Beclin1  LC3-II  Western blot
基金项目:国家自然科学基金面上项目(81570295)
作者单位E-mail
杜 琎 南京中医药大学附属中西医结合医院 心胸外科 江苏 南京 210028 dujin810106@163.com 
石开虎 南京中医药大学附属中西医结合医院 心胸外科 江苏 南京 210028  
赵 扬 南京中医药大学附属中西医结合医院 心胸外科 江苏 南京 210028  
胡定辉 南京中医药大学附属中西医结合医院 心胸外科 江苏 南京 210028  
李 航 南京中医药大学附属中西医结合医院 心胸外科 江苏 南京 210028  
刘尊涛 南京中医药大学附属中西医结合医院 心胸外科 江苏 南京 210028  
摘要点击次数: 1031
全文下载次数: 892
中文摘要:
      摘要 目的:研究丹参酚酸B(SA-B)能否通过抑制PI3K/AKT/mTOR通路促进自噬,从而减轻大鼠心肌纤维化。方法:选用SD大鼠40只,完全随机化分为对照组、模型组、低剂量SA-B治疗组和高剂量SA-B治疗组,采用皮下注射异丙肾上腺素(ISO)构建大鼠心肌纤维化模型。低、高剂量SA-B治疗组在造模同时灌喂丹参酚酸B水溶液,对照组和模型组分别灌胃等体积0.9%生理盐水。测定心重指数(HW/BW)和左心室重指数(LVW/BW);ELISA法测定心肌中I型、III型胶原水平;Western blot检测自噬相关蛋白PI3K、AKT、p-AKT、mTOR、Beclin1、LC3-II水平;大鼠心肌HE染色评估心肌纤维化程度。结果:与对照组比较,模型组中大鼠的心重指数、左心室重指数和心肌中I型、III型胶原的水平升高(P<0.05),HE染色结果提示心肌组织发生明显的纤维化。模型组大鼠心肌细胞中的自噬相关蛋白PI3K、AKT、p-AKT 、mTOR表达升高,Beclin1、LC3-II表达较对照组明显降低(P<0.05)。SA-B组中心重指数、左心室重指数和心肌中I型、III型胶原的水平明显降低,HE染色未见明显纤维化病灶,其自噬相关蛋白PI3K、AKT、p-AKT 、mTOR表达降低,Beclin1、LC3-II表达较模型组明显升高(P<0.05)。结论:丹参酚酸B能够抑制ISO所致的大鼠心肌纤维化,且具有剂量依耐性,其机制与抑制PI3K/AKT/mTOR传导通路促进细胞自噬密切相关。
英文摘要:
      ABSTRACT Objective: To investigative whether the salvianolic acid B (SA-B) could inhibit the PI3K/AKT/mTOR pathway to promote the autophagy, thereby reducing rat myocardial fibrosis. Methods: A total of 40 SD rats underwent the complete randomization and were assigned to four groups: the control group, model group, low-dose and high-dose SA-B group. The rat myocardial fibrosis model was established by subcutaneous injection of isoproterenol (ISO). For treatment groups with low- and high-dose SA-B, the modeling was performed while feeding rats with SA-B aqueous solution was conducted, and 0.9% of normal saline with the same volume was administrated in the control and model groups. The heart weight and body weight index (HW/BW) and left ventricular weight and body weight index (LVW/BW) were measured; the ELISA method was used to detect the type I and III collagen levels in myocardia; the levels of autophagy-related proteins, PI3K, AKT, p-AKT, mTOR, Beclin1, LC3-II were detected by using Western blot; the HE staining in rat myocardia was used for the assessment on the degree of myocardial fibrosis. Results: As compared with the control group, it showed an increase for the model group in HW/BW, LVW/BW and type I and III collagen levels in myocardia (P<0.05), and the results of HE staining suggested the significant fibrosis for myocardia. In the model group, it had an increase in expression levels of autophagy-related proteins, PI3K, AKT, p-AKT, mTOR and a significant decrease in expression levels of Beclin1 and LC3-II as compared with the control group (P<0.05). In the SA-B group, it showed an obvious decrease in HW/BW, LVW/BW and type I and III collagen levels in myocardia, and the HE staining suggested no significant fibrosis, and it showed a decrease for expression levels of autophagy-related proteins, PI3K, AKT, p-AKT, mTOR and significant increase for expression levels of Beclin1 and LC3-II as compared with the model group (P<0.05). Conclusion: The SA-B could inhibit rat myocardial fibrosis caused by ISO in a dose-dependent manner, and its mechanism was closely associated with autophagy promoting by the inhibition of PI3K/AKT/mTOR pathway.
查看全文   查看/发表评论  下载PDF阅读器
关闭